SEC CRD #802-128958
Luma Group Menu © 2026 Luma Group. All rights reserved Contact us contactus@lumagroup.com © 2026 Luma Group. All rights reserved Investing in the science that defines tomorrow’s medicine Explore Portfolio Meet our Team Luma Group is a multistage investment firm focused on biotechnology, bringing together scientific insight and computation to shape both our investment strategy and the companies we back. Explore Portfolio First-principles science We partner with teams that have deep biological conviction—grounded in data and clear paths to translation that can become durable, scalable patient impact. Accelerated insight with LABI Our AI system speeds up how we analyze data, validate breakthroughs, and uncover real potential. Hands-on industry leadership We go beyond financial capital to work with founders that are innovating at the edge of innovative healthcare solutions. Breakthrough science. Disciplined execution. We back teams translating breakthrough biology into therapies, diagnostics, and medical devices that can scale impact for patients. Explore Portfolio Research, analysis, and updates from our network Articles, whitepapers, and expert commentary. See More Insights Articles May 7, 2026 CEO Q A: Curve Biosciences on Transforming Disease Detection Through Blood-Based Insights At Luma Group, we partner with companies that are redefining the frontiers of healthcare through data, AI, and deep biological insight. Curve Biosciences is one such company, building a platform aim
Luma Group
CHIEF FINANCIAL OFFICER, AUTHORIZED SIGNATORY
📞 (917) 952-7860
🔒 Sign up for free to view key contact information
Sign up free →This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
Location
NEW YORK, NY
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.